Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats |
| |
Authors: | Tetsuya Hirano MD Dr. Tadao Manabe MD Takayoshi Tobe MD |
| |
Affiliation: | (1) Department of Surgery, Faculty of Medicine, Kyoto University, 54 Shogoin-Kawaracho, Sakyoku, 606 Kyoto, Japan |
| |
Abstract: | We evaluated the protective effect and the mechanism of action of the trypsin inhibitor, urinastatin, extracted from human urine, in experimental acute pancreatitis induced by a supramaximal dose of cerulein (5 g/kg/hr for 3.5 hr). Urinastatin in a dose of 10,000 units/kg/hr was given by three different methods of continuous infusion: (1) 2 hr before and during cerulein infusion, (2) only during cerulein infusion, and (3) starting 1 hr after the beginning of cerulein infusion and continued for 3.5 hr. In protocol 1 and 2 urinastatin was significantly more protective than in 3. In protocol 1 urinastatin was very protective in all parameters tested (serum amylase level, pancreatic water and amylase content, distribution of lysosomal enzymes, cellular and lysosomal fragility). These results suggest that the administration of urinastatin before and during cerulein infusion may suppress the pathogenesis and evolution of pancreatitis by inhibiting the chain reaction of pancreatic enzyme activation closely related to redistribution of lysosomal enzyme and lysosomal fragility. |
| |
Keywords: | cerulein acute pancreatitis urinastatin lysosomal enzyme |
本文献已被 SpringerLink 等数据库收录! |
|